Question explored with the scientific record
Conversation so far
- 1 How many times should someone have blood tests when taking Lithium
- 2 What tests besides lithium level should be done, and how often?
- 3 What symptoms mean I should get urgent lithium level and kidney/thyroid testing?
- 4 900 mg daily does that require sooner testings
Answered on this page ↓
900 mg daily does that require sooner testings
The short version: 900 mg daily is a common dose, but it does not by itself dictate testing frequency — individual factors matter more.
The one study that directly examined 900 mg/day lithium found that serum levels varied widely, from 0.31 to 1.51 mmol/L, even at the same dose [7]. Only 84.6% of patients were in the therapeutic range; 12.2% were sub-therapeutic and 3.3% were supra-therapeutic [7]. This means the same dose produces very different blood levels in different people.
Standard monitoring guidelines recommend checking lithium levels every 3 months once stable, with sooner testing after dose changes (within 1 week) and whenever toxicity symptoms appear [6]. The target range for most adults is 0.6–1.0 mmol/L, with lower targets (0.4–0.8 mmol/L) for older adults [1][6].
The real question is not the dose but the level and the person. A 900 mg dose that produces a level above 1.0 mmol/L requires immediate adjustment and closer monitoring [3]. Women experience more adverse reactions than men at the same dose [7]. Older adults, people with lower kidney function, and those on other medications need tighter surveillance [3][5].
| Factor | Effect on monitoring |
|---|---|
| Serum lithium level above 1.0 mmol/L | Urgent dose reduction + repeat level within days [3] |
| Female gender | Higher adverse reaction risk at same dose [7] |
| Age over 60 | Lower target range (0.4–0.8 mmol/L) [1] |
| Pre-existing kidney disease | More frequent creatinine checks [3] |
| New neurological symptoms | Same-day level + kidney panel [2][4] |
The evidence does not support a blanket rule that 900 mg requires sooner testing. It supports testing based on the actual blood level, kidney function, age, sex, and symptoms. A patient on 900 mg with a level of 0.6 mmol/L and stable kidneys does not need more frequent testing than standard. A patient on 900 mg with a level of 1.1 mmol/L needs immediate action.
My call: the dose alone does not determine testing frequency — the serum level, kidney function, age, and symptoms do. Confidence: high.
Sources used 7
-
Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: An ISBD task force report
In a three-round ISBD Delphi survey of 25 psychiatrists, experts reached 100% consensus that lithium is the preferred maintenance monotherapy for older adults with bipolar disorder and recommended target serum lithium ranges of 0.4-0.8 mmol/L for ages 60-79 and 0.4-0.7 mmol/L fo…
DOI: 10.1111/bdi.12714 -
Mood‐dependent changes of serum lithium concentration in a rapid cycling patient maintained on stable doses of lithium carbonate
In a rapid-cycling bipolar II patient on nearly constant lithium carbonate, serum lithium was markedly lower in mania (0.39 mmol/L) than depression (0.67 mmol/L), with a 5-6 day lag behind mood shifts.
DOI: 10.1111/bdi.12066 -
Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification
A narrative literature review synthesizing evidence on lithium-associated nephrotoxicity, its risks, clinical management, and risk stratification to guide decisions for long-term lithium therapy in bipolar disorder.
DOI: 10.1186/s12882-018-1101-4 -
Lithium Toxicity: A Case Report
A 46-year-old woman with bipolar disorder on chronic lithium presented with lithium toxicity and acute kidney injury; lithium discontinuation and haemodialysis led to clinical improvement, but she developed persistent lithium-induced nephrogenic diabetes insipidus.
DOI: 10.1192/bjo.2025.10721 -
Risk factors for polyuria in a cross‐section of community psychiatric lithium‐treated patients
This cross-sectional study of lithium-treated psychiatric patients identifies female gender and higher body weight as independent predictors of polyuria, with lean body weight (LBW) being the strongest predictor of both polyuria presence and higher 24-hour urine volume, highligh…
DOI: 10.1111/bdi.12235 -
Best practice in primary care pathology: review 5
A consensus-based best-practice review summarizing guidance for three common primary-care laboratory questions (minor liver function test abnormalities, lithium safety monitoring, and D-dimer/DVT assessment), synthesizing national/international guidance to provide practical test…
DOI: 10.1136/jcp.2006.037754 -
Pattern of adverse drug reactions and serum level of maintenance lithium treatment in patients with bipolar affective disorder: a cross-sectional study in Eastern Nepal
Among 123 euthymic bipolar outpatients in Eastern Nepal on lithium 900 mg/day, serum levels varied widely and were therapeutic in 84.6%, while 65.9% had adverse drug reactions.
DOI: 10.18203/issn.2454-2156.intjscirep20212392